These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36338995)

  • 1. Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study.
    Liu S; Zhao L; Zhou G
    Front Genet; 2022; 13():1016085. PubMed ID: 36338995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab.
    Sánchez-Gastaldo A; Muñoz-Fuentes MA; Molina-Pinelo S; Alonso-García M; Boyero L; Bernabé-Caro R
    Transl Lung Cancer Res; 2021 Jun; 10(6):2509-2522. PubMed ID: 34295658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
    Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
    Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non-small cell lung cancer.
    Lu X; Wan J; Shi H
    Oncol Lett; 2022 Aug; 24(2):266. PubMed ID: 35782904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).
    Li Y; Zhang Z; Hu Y; Yan X; Song Q; Wang G; Chen R; Jiao S; Wang J
    Front Oncol; 2020; 10():654. PubMed ID: 32656072
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
    Hidalgo-Ríos S; Carrillo-García J; Moura DS; Stacchiotti S; López-Pousa A; Redondo A; Italiano A; Gutiérrez A; Grignani G; Hindi N; López-Guerrero JA; Muro XGD; Trufero JM; Palmerini E; García AS; Bernabeu D; Le Cesne A; Casali PG; Blay JY; Cruz Jurado J; Martin-Broto J
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
    Yu J; Ding Z; Yang Y; Liu S
    Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer.
    Staniewska E; Tomasik B; Tarnawski R; Łaszczych M; Miszczyk M
    Rep Pract Oncol Radiother; 2021; 26(6):1010-1018. PubMed ID: 34992875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
    Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
    BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors.
    Pu D; Xu Q; Zhou LY; Zhou YW; Liu JY; Ma XL
    Thorac Cancer; 2021 Nov; 12(21):2914-2923. PubMed ID: 34581010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients.
    Gonçalves JM; Carvalho B; Tuna R; Polónia P; Linhares P
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
    Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer.
    Wang L; Si H; Wang J; Feng L; Zhai W; Dong S; Yu Z
    Oncol Lett; 2020 Aug; 20(2):1101-1110. PubMed ID: 32724349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
    Wang Y; Zhang H; Yang Y; Zhang T; Ma X
    Front Oncol; 2019; 9():995. PubMed ID: 31649874
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
    Zhang N; Jiang J; Tang S; Sun G
    Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.